| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| [Can the mini-pills be taken cyclically?]. | 1972 | Tidsskr. Nor. Laegeforen. | pmid:4649638 | |
| Bergsjo P | [Extrauterine pregnancy during the use of mini-pills]. | 1975 | Tidsskr. Nor. Laegeforen. | pmid:48289 |
| Stray-Pedersen B | [The minipill]. | 1973 | Tidsskr. Nor. Laegeforen. | pmid:4693979 |
| Juvkam KH and Gudim HB | [Drug induced displacement of menstruation]. | 2013 | Tidsskr. Nor. Laegeforen. | pmid:23344601 |
| Skjeldestad FE | Prescribing contraception for young women. | 2012 | Tidsskr. Nor. Laegeforen. | pmid:22314738 |
| Bergsjo P | [Conception control by daily use of low dose gestagen pills]. | 1969 | Tidsskr. Nor. Laegeforen. | pmid:4193912 |
| Brosnan JF et al. | Norethisterone acetate alters coagulation gene expression in vitro in human cell culture. | 2013 | Thromb. Res. | pmid:22999413 |
| Dahm AE et al. | A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. | 2012 | Thromb. Res. | pmid:22217510 |
| Kjaeldgaard A et al. | Progestogen regulation of tissue plasminogen activator in a human melanoma cell line. | 1988 | Thromb. Res. | pmid:3129818 |
| Eilertsen AL et al. | Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. | 2007 | Thromb. Res. | pmid:17156824 |
| Cole ER | Effect of steroids, including progestin and estrogen components of oral contraceptive drugs, on the esterase activity of thrombin. | 1974 | Thromb. Res. | pmid:4428464 |
| Sgarabotto M et al. | Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study. | 2007 | Thromb. Res. | pmid:16499954 |
| Schaudig K and Thomssen C | Hormonal therapy with patch or pill: how much does it matter? | 2007 | Thromb. Haemost. | pmid:17393010 |
| Brosnan JF et al. | Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? | 2007 | Thromb. Haemost. | pmid:17393018 |
| Eilertsen AL et al. | Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. | 2007 | Thromb. Haemost. | pmid:17549295 |
| Kennedy G et al. | Elevated levels of sE-selectin in post-menopausal females are decreased by hormone replacement therapy to levels observed in pre-menopausal females. | 1999 | Thromb. Haemost. | pmid:10595633 |
| Høibraaten E et al. | The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. | 2001 | Thromb. Haemost. | pmid:11372667 |
| Anglade JP | [Norethisterone acetate and endometriosis. Clinical study apropos of 10 cases]. | 1972 Sep-Oct | Therapie | pmid:4651404 |
| Eben-Moussi E and van den Driessche J | [Evaluation of the biological activity of a new progestational hormone: quingestanol acetate]. | 1970 Jan-Feb | Therapie | pmid:5436801 |
| Anglade JP | [Clinical study of norethisterone acetate in functional metrorrhagia and in pre- and permenstrual painful syndromes]. | 1972 Sep-Oct | Therapie | pmid:4675625 |
| Keller PJ | [Hormonal contraception using depot preparations]. | 1986 | Ther Umsch | pmid:2941890 |
| Altmayer P et al. | Experiences with Norcolut (a new therapeutic gestagen). | 1978 | Ther Hung | pmid:684654 |
| Domány Z and Varga A | Examinations with a monohormonal oral contraceptive agent (continuin). | 1975 | Ther Hung | pmid:54943 |
| Fekete G | Chemistry, pharmacology and clinical pharmacology of oral contraceptives. | 1968 | Ther Hung | pmid:12334483 |
| Maclaughlin EJ et al. | Management of age-related osteoporosis and prevention of associated fractures. | 2006 | Ther Clin Risk Manag | pmid:18360603 |
| Beatty MN and Blumenthal PD | The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability. | 2009 | Ther Clin Risk Manag | pmid:19707273 |
| Neely M and Kovacs A | Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir. | 2009 | Ther Clin Risk Manag | pmid:19707276 |
| Wright KP and Johnson JV | Evaluation of extended and continuous use oral contraceptives. | 2008 | Ther Clin Risk Manag | pmid:19209272 |
| Krishna A et al. | Modeling CICR in rat ventricular myocytes: voltage clamp studies. | 2010 | Theor Biol Med Model | pmid:21062495 |
| Buttram VC and Kaufman RH | Primary dysmenorrhea: combination vs sequential therapy. | 1969 | Tex Med | pmid:4185963 |
| Prahalada S and Hendrickx AG | Embryotoxicity of Norlestrin, a combined synthetic oral contraceptive, in rhesus macaques (Macaca mulatta). | 1983 | Teratology | pmid:6867943 |
| Hendrickx AG et al. | Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus). | 1987 | Teratology | pmid:3563930 |
| Pulkkinen MO et al. | Norethisterone acetate and ethinylestradiol in early human pregnancy. | 1984 | Teratology | pmid:6429876 |
| Kukhtevich AV et al. | [Nephropathy-related disorders of physical and sexual development in girls: experience with successful stimulation by zinc, parlodel and norcolut]. | 1993 | Ter. Arkh. | pmid:8378851 |
| Gong Z et al. | Simple and rapid determination of norethindrone in human plasma by supported liquid extraction and ultra performance liquid chromatography with tandem mass spectrometry. | 2012 | Talanta | pmid:22365683 |
| Huang CY et al. | The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study. | 2009 | Taiwan J Obstet Gynecol | pmid:19346194 |
| Chen FP et al. | Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. | 2013 | Taiwan J Obstet Gynecol | pmid:24075375 |
| Mendenhall HW | Effect of oral contraceptives on serum protein concentrations. | 1969 | Surg Forum | pmid:5383101 |
| Walther Meade C et al. | A clinical study of norethisterone enanthate in rural Mexico. | 1984 May-Jun | Stud Fam Plann | pmid:6740731 |
| Cellitti SE et al. | Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824. | 2012 | Structure | pmid:22244759 |
| Xuereb M and Pullicino P | Oral contraceptive use and risk of stroke. | 1988 | Stroke | pmid:3388464 |
| Williams JG et al. | Metabolism of 4-3-H- and 4-14-C-17alpha-ethynylestradiol 3-methyl ether (mestranol) by women. | 1975 | Steroids | pmid:1145671 |
| KratochvÃl P et al. | Sustained release hormonal preparations. 6. Permeability constant of various steroids. | 1970 | Steroids | pmid:5446544 |
| Briggs MH | Steroid hormones and the fertilizing capacity of spermatozoa. | 1973 | Steroids | pmid:4127001 |
| Leung SL et al. | Norethisterone and levonorgestrel esters: a novel synthetic method. | 1985 | Steroids | pmid:3939269 |
| Herz JE et al. | Preparation of 19-nor-17alpha-ethinyltestosterone pivalate ester. | 1977 | Steroids | pmid:919011 |
| Longcope C et al. | The effects of synthetic estrogens on the metabolic clearance and production rates of estrone and estradiol. | 1974 | Steroids | pmid:4843804 |
| Gal D et al. | Failure of contraceptive steroids to modify human chorionic gonadotrophin secretion by hydatidiform mole tissue and choriocarcinoma cells in culture. | 1981 | Steroids | pmid:7027540 |
| Bélanger A et al. | Regio and stereospecific synthesis of 11 beta-substituted 19-norsteroids. Influence of 11 beta-substitution on progesterone receptor affinity - (1). | 1981 | Steroids | pmid:7245285 |
| Kappus H and Bolt HM | Irreversible protein binding of norethisterone (norethindrone) epoxide. | 1976 | Steroids | pmid:4905 |
| Joshi JV et al. | Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses. | 1989 | Steroids | pmid:2815152 |
| Müller J and Herz JE | Preparation of highly hindered steroid esters: application of some newer methods of esterification. | 1979 | Steroids | pmid:538779 |
| Johnston JO et al. | Regioselectivity of metabolic activation of acetylenic steroids by hepatic cytochrome P450 isozymes. | 1991 | Steroids | pmid:1871782 |
| Matlin SA et al. | Long-acting contraceptive agents: analysis and purification of steroid esters. | 1983 | Steroids | pmid:6419409 |
| Naderi S and Fotherby K | Long-acting contraceptive agents: in vitro hydrolysis of esters of norethisterone and levonorgestrel. | 1983 | Steroids | pmid:6419410 |
| Bialy G et al. | Long-acting contraceptive agents: structure activity relationships in a series of norethisterone and levonorgestrel esters. | 1983 | Steroids | pmid:6419411 |
| Walker CJ et al. | Doping in sport--2. Quantification of the impurity 19-norandrostenedione in pharmaceutical preparations of norethisterone. | 2009 | Steroids | pmid:19010341 |
| Farkas E and O'Toole DJ | 17 alpha-ethynyl-17 beta-hydroxy-10 alpha-estr-4-en-3-one. | 1971 | Steroids | pmid:5551842 |
| Jones RC et al. | An assay for progestagens by the intravenous route. | 1966 | Steroids | pmid:5962978 |
| Murugesan K et al. | Effect of progestins, estradiol, and coenzymes NAD and NADPH on the interconversion of estradiol and estrone in rabbit uterus in vitro. | 1989 | Steroids | pmid:2554542 |
| Pedersen SH et al. | Medroxyprogesterone acetate attenuates long-term effects of 17beta-estradiol in coronary arteries from hyperlipidemic rabbits. | 2006 | Steroids | pmid:16815506 |
| Vincze I et al. | Steroids 49. Investigations on the dehydration of 17 alpha-ethynyl-17 beta-hydroxysteroids. | 1993 | Steroids | pmid:8356574 |
| Dean HJ and Winter JS | The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers. | 1984 | Steroids | pmid:6523531 |
| Ambrus G et al. | Microbiological 1 alpha-hydroxylation of norethisterone. | 1975 | Steroids | pmid:1167432 |
| de Gooyer ME et al. | Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. | 2003 | Steroids | pmid:12628686 |
| Rao PN | Preparation of 9-alpha,11-xi-tritiated 17-alpha-ethynylestradiol, mestranol, estradiol-alpha-17-beta, and norethindrone. | 1971 | Steroids | pmid:5126820 |
| Sasagawa S et al. | Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. | 2008 | Steroids | pmid:18061638 |
| Ekhato IV et al. | Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references. | 2002 | Steroids | pmid:11856540 |
| Ringler I | Efficacy of topically applied progestational agents. | 1966 | Steroids | pmid:4163760 |
| Curts SW et al. | Synthesis of 5 beta,17 alpha-19-norpregn-20-yne-3 beta,17-diol and of 5 beta,17 alpha-19-norpregn-20-yne-3 alpha,17-diol, human metabolites of norethindrone. | 1991 | Steroids | pmid:2028483 |
| Williams JG and Williams KI | Metabolism of 2-3H- and 4-14C-17alpha-ethynylestradiol 3-methyl ether (mestranol) by women. | 1975 | Steroids | pmid:1216258 |
| Johnson AL | Aliphatic esters of 6,6-difluoro-17 -hydroxy-17-ethynyl-4-estren-3-one (6,6-difluoronorethindrone) and (+)-6,6-difluoro-13 -ethyl-17 -hydroxy-17-ethynyl-4-gonen-3-one ((+)-6,6-difluoronorgestrel). | 1972 | Steroids | pmid:5073576 |
| Walker CJ et al. | Doping in sport: 3. Metabolic conversion of oral norethisterone to urinary 19-norandrosterone. | 2009 | Steroids | pmid:19059424 |
| Walker CJ et al. | Doping in sport--1. Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone. | 2009 | Steroids | pmid:19010339 |
| DiNunno CM et al. | 7 alpha-Methylnorethindrone enanthate 10 beta-hydroperoxide: isolation and characterization. | 1983 | Steroids | pmid:6689617 |
| Raobaikady B et al. | Lack of aromatisation of the 3-keto-4-ene metabolite of tibolone to an estrogenic derivative. | 2006 | Steroids | pmid:16712888 |
| Crabbé P et al. | Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme. | 1983 | Steroids | pmid:6658872 |
| Adamczyk M et al. | O-(fluoresceinylmethyl)hydroxylamine (OFMHA): a reagent for the preparation of fluorescent O-(fluoresceinylmethyl)oxime (FMO)-steroid conjugates. | 1999 | Steroids | pmid:10399885 |
| Watson TG et al. | Long-acting contraceptive agents: esters of norethisterone with alpha- and/or beta-chain branching. | 1983 | Steroids | pmid:6658873 |
| Herz JE et al. | Esterification of acid chlorides with thallium and potassium salts of 19-norethisterone: formation of 17-enol esters. | 1982 | Steroids | pmid:7184202 |
| Francisco CG et al. | Long-acting contraceptive agents: norethisterone esters of monoalkenyl and monoalkynyl acids. | 1983 | Steroids | pmid:6658874 |
| Francisco CG et al. | Long-acting contraceptive agents: norethisterone esters of polyunsaturated acids. | 1983 | Steroids | pmid:6658875 |
| Shafiee A et al. | Long-acting contraceptive agents: esters of norethisterone with alkoxy- and halogeno-substituted carboxylic acids. | 1983 | Steroids | pmid:6658876 |
| Terenius L | Specific progestogen binder in uterus of normal rats. | 1972 | Steroids | pmid:4114433 |
| Shafiee A et al. | Long-acting contraceptive agents: cyclopropyl and cyclobutyl esters of norethisterone. | 1983 | Steroids | pmid:6658877 |
| Wan AS et al. | Long-acting contraceptive agents: norethisterone esters of arylcarboxylic acids. | 1983 | Steroids | pmid:6658878 |
| Wan AS et al. | Long-acting contraceptive agents: furylalkylcarboxylic acid esters of norethisterone. | 1983 | Steroids | pmid:6658879 |
| Turkes A et al. | A sensitive solid phase enzymeimmunoassay for norethisterone (norethindrone) in saliva and plasma. | 1980 | Steroids | pmid:6990558 |
| Herz JE and Sandoval J | Long-acting contraceptive agents: bile acid esters of norethisterone. | 1983 | Steroids | pmid:6658880 |
| Herz JE et al. | Long-acting contraceptive agents: carbonates and carbamates of norethisterone. | 1983 | Steroids | pmid:6658881 |
| Enever RP and Lewis GA | Long-acting contraceptive agents: the influence of pharmaceutical formulation upon biological activity of esters of norethisterone. | 1983 | Steroids | pmid:6658882 |
| Enever RP et al. | Long-acting contraceptive agents: the influence of physico-chemical properties of some esters of norethisterone upon the plasma levels of free norethisterone. | 1983 | Steroids | pmid:6658883 |
| Garza-Flores J et al. | A rapid and sensitive radioimmunoassay for norethisterone. | 1983 | Steroids | pmid:6665817 |
| Bakos T et al. | Steroids 51. An improved synthesis of ORG 2058 and the synthesis of [3H]ORG 2058. | 1993 | Steroids | pmid:8475515 |
| Kincl FA et al. | Sustained release hormonal preparations. 1. Diffusion of various steroids through polymer membranes. | 1968 | Steroids | pmid:5650692 |
| EVANS DD and PALMER PJ | STEROID ESTERS OF DIBASIC ACIDS. | 1965 | Steroids | pmid:14303098 |
| Düsterberg B | Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey. | 1984 | Steroids | pmid:6240802 |
| Banerjee RC et al. | Effects of norethindrone (17-ethynyl-17 -hydroxy-4-estren-3-one) and norgestrel (dl-13 -ethyl-17-ethynyl-17 -hydroxy-4-gonen-3-one) on the tissue distribution of 3 H-estradiol-17 in ovariectomized rats. | 1973 | Steroids | pmid:4687305 |
| Watanabe H | The in vitro inhibition of estrogen transformations in rat liver by 17-alpha-ethynyl-19-norsteroids. | 1969 | Steroids | pmid:5773889 |
| Cooper GF | Synthesis of 5,17-dihydroxy-5 alpha, 17 alpha,-19-norpregn-20-yn-3-one, a major photodegradation product of norethindrone. | 1988 May-Jun | Steroids | pmid:3242171 |